These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Dynamics of HIV-1 quasispecies diversity of participants on long-term antiretroviral therapy based on intrahost single-nucleotide variations. Zhang Y; Yin Q; Ni M; Liu T; Wang C; Song C; Liao L; Xing H; Jiang S; Shao Y; Chen C; Ma L Int J Infect Dis; 2021 Mar; 104():306-314. PubMed ID: 33444750 [TBL] [Abstract][Full Text] [Related]
6. HIV evolution and diversity in ART-treated patients. van Zyl G; Bale MJ; Kearney MF Retrovirology; 2018 Jan; 15(1):14. PubMed ID: 29378595 [TBL] [Abstract][Full Text] [Related]
7. Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART. Puertas MC; Noguera-Julian M; Massanella M; Pou C; Buzon MJ; Clotet B; Stevenson M; Paredes R; Blanco J; Martinez-Picado J Retrovirology; 2016 Aug; 13(1):51. PubMed ID: 27484989 [TBL] [Abstract][Full Text] [Related]
8. Greater diversity of HIV DNA variants in the rectum compared to variants in the blood in patients without HAART. Avettand-Fenoel V; Hocqueloux L; Müller-Trutwin M; Prazuck T; Melard A; Chaix ML; Agoute E; Michau C; Rouzioux C J Med Virol; 2011 Sep; 83(9):1499-507. PubMed ID: 21739438 [TBL] [Abstract][Full Text] [Related]
9. HIV Diversity and Genetic Compartmentalization in Blood and Testes during Suppressive Antiretroviral Therapy. Miller RL; Ponte R; Jones BR; Kinloch NN; Omondi FH; Jenabian MA; Dupuy FP; Fromentin R; Brassard P; Mehraj V; Chomont N; Poon AFY; Joy JB; Brumme ZL; Routy JP; J Virol; 2019 Sep; 93(17):. PubMed ID: 31189714 [TBL] [Abstract][Full Text] [Related]
10. Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers. de Azevedo SSD; Caetano DG; Côrtes FH; Teixeira SLM; Dos Santos Silva K; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G Retrovirology; 2017 May; 14(1):29. PubMed ID: 28464889 [TBL] [Abstract][Full Text] [Related]
11. Review: Influence of ART on HIV genetics. Simonetti FR; Kearney MF Curr Opin HIV AIDS; 2015 Jan; 10(1):49-54. PubMed ID: 25389802 [TBL] [Abstract][Full Text] [Related]
12. Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy. Frenkel LM; Wang Y; Learn GH; McKernan JL; Ellis GM; Mohan KM; Holte SE; De Vange SM; Pawluk DM; Melvin AJ; Lewis PF; Heath LM; Beck IA; Mahalanabis M; Naugler WE; Tobin NH; Mullins JI J Virol; 2003 May; 77(10):5721-30. PubMed ID: 12719565 [TBL] [Abstract][Full Text] [Related]
13. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930 [TBL] [Abstract][Full Text] [Related]
14. Absence of genetic diversity reduction in the HIV-1 integrated proviral LTR sequence population during successful combination therapy. Ibáñez A; Clotet B; Martínez MA Virology; 2001 Mar; 282(1):1-5. PubMed ID: 11259184 [TBL] [Abstract][Full Text] [Related]
15. Genetic analyses reveal structured HIV-1 populations in serially sampled T lymphocytes of patients receiving HAART. Potter SJ; Lemey P; Dyer WB; Sullivan JS; Chew CB; Vandamme AM; Dwyer DE; Saksena NK Virology; 2006 Apr; 348(1):35-46. PubMed ID: 16455126 [TBL] [Abstract][Full Text] [Related]
16. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. Zhu T; Muthui D; Holte S; Nickle D; Feng F; Brodie S; Hwangbo Y; Mullins JI; Corey L J Virol; 2002 Jan; 76(2):707-16. PubMed ID: 11752161 [TBL] [Abstract][Full Text] [Related]
17. Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure. Sharkey M; Babic DZ; Greenough T; Gulick R; Kuritzkes DR; Stevenson M PLoS Pathog; 2011 Feb; 7(2):e1001303. PubMed ID: 21383975 [TBL] [Abstract][Full Text] [Related]
18. HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer. Rose R; Lamers SL; Nolan DJ; Maidji E; Faria NR; Pybus OG; Dollar JJ; Maruniak SA; McAvoy AC; Salemi M; Stoddart CA; Singer EJ; McGrath MS J Virol; 2016 Oct; 90(20):8984-93. PubMed ID: 27466425 [TBL] [Abstract][Full Text] [Related]
19. Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy. von Stockenstrom S; Odevall L; Lee E; Sinclair E; Bacchetti P; Killian M; Epling L; Shao W; Hoh R; Ho T; Faria NR; Lemey P; Albert J; Hunt P; Loeb L; Pilcher C; Poole L; Hatano H; Somsouk M; Douek D; Boritz E; Deeks SG; Hecht FM; Palmer S J Infect Dis; 2015 Aug; 212(4):596-607. PubMed ID: 25712966 [TBL] [Abstract][Full Text] [Related]
20. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes. Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]